The Smear test is a screening method used to detect cervical cancer and has limited capability for definitive diagnosis. Therefore, when suspicious findings are detected in a Smear test, a cervical biopsy is essential for a definitive diagnosis and grading.

Tissues obtained through cervical biopsy are sent for pathological examination. The results of this examination may primarily report the following conditions:

1. Normal Cells: Despite findings in the Smear test suggesting abnormalities, the biopsy result may sometimes be reported as normal. In this case, repeating the Smear test after 3-6 months is recommended.

2. CIN-1 (Cervical Intraepithelial Neoplasia Grade 1): In this situation, repeating the Smear test after 3-4 months is generally deemed appropriate.

3. CIN-2 (Cervical Intraepithelial Neoplasia Grade 2) or CIN-3 (Cervical Intraepithelial Neoplasia Grade 3): If CIN-2 or CIN-3 is detected in the biopsy result, the affected upper layer of the cervix is removed using the LEEP (Loop Electrosurgical Excision Procedure) method. This tissue, approximately the size of a thumbnail, is sent for detailed pathological examination.

4. Invasive Cervical Cancer: If invasive cervical cancer is diagnosed based on the cervical biopsy result, the treatment plan may include methods such as removal of the uterus (hysterectomy), lymph node biopsy, radiotherapy, and/or chemotherapy.